Risk factors and prognosis of intravesical recurrence after surgical management of upper tract urothelial carcinoma: A 30-year single centre experience

Objective: To review the incidence, predictors and prognosis of bladder cancer recurrence after management of upper tract urothelial carcinoma (UTUC). Patients and methods: We retrospectively reviewed patients who were surgically treated for UTUC from 1983 to 2013. The tumours were categorised accor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mohamed Mohamed Elawdy, Yasser Osman, Diaa Eldin Taha, Mohamed H. Zahran, Samer El-Halwagy, Muftah El Garba, Ahmed M. Harraz
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2017
Materias:
Acceso en línea:https://doaj.org/article/28437e20a2474d54a29d2ed08b104409
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:28437e20a2474d54a29d2ed08b104409
record_format dspace
spelling oai:doaj.org-article:28437e20a2474d54a29d2ed08b1044092021-12-02T08:22:58ZRisk factors and prognosis of intravesical recurrence after surgical management of upper tract urothelial carcinoma: A 30-year single centre experience2090-598X10.1016/j.aju.2017.03.006https://doaj.org/article/28437e20a2474d54a29d2ed08b1044092017-09-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2090598X17300426https://doaj.org/toc/2090-598XObjective: To review the incidence, predictors and prognosis of bladder cancer recurrence after management of upper tract urothelial carcinoma (UTUC). Patients and methods: We retrospectively reviewed patients who were surgically treated for UTUC from 1983 to 2013. The tumours were categorised according to the 1997 Tumour-Node-Metastasis (TNM) staging and the three-tiered World Health Organization grading systems. The primary endpoint was the occurrence of any intravesical recurrence after treatment. We studied the possible risk factors that may contribute to development of intravesical recurrence, as well as the prognosis of the patients who had recurrence. Results: In all, 297 patients were eligible for analysis. Recurrent bladder tumours occurred in 139 patients (46.8%). The mean (range) time to recurrence after surgery was 33 (6–300) months. Neither sex, past history of bladder tumours, concomitant bladder tumour, the side of the tumour, UTUC stage, grade, presence of carcinoma in situ or multicentricity at the time of diagnosis of UTUC, were significant predictors of intravesical tumour recurrence. Ureteric tumour was the only identified risk factor (P = 0.02). Post-treatment bladder recurrence was a significant predictor of later urethral recurrence (P = 0.002). Conclusions: In our present series, bladder cancer recurrence of urothelial malignancy occurred in nearly half of the patients after surgical management of UTUC. Ureteric tumour was the only identifiable risk factor, thus patients with ureteric tumours may benefit from prophylactic intravesical chemoimmunotherapy. Bladder recurrence does not appear to affect the cancer-specific survival after surgical management of UTUC.Mohamed Mohamed ElawdyYasser OsmanDiaa Eldin TahaMohamed H. ZahranSamer El-HalwagyMuftah El GarbaAhmed M. HarrazTaylor & Francis GrouparticleUrological neoplasmsTransitional cell carcinomaUreteric neoplasmsUrinary bladder neoplasmsIntravesical recurrenceDiseases of the genitourinary system. UrologyRC870-923ENArab Journal of Urology, Vol 15, Iss 3, Pp 216-222 (2017)
institution DOAJ
collection DOAJ
language EN
topic Urological neoplasms
Transitional cell carcinoma
Ureteric neoplasms
Urinary bladder neoplasms
Intravesical recurrence
Diseases of the genitourinary system. Urology
RC870-923
spellingShingle Urological neoplasms
Transitional cell carcinoma
Ureteric neoplasms
Urinary bladder neoplasms
Intravesical recurrence
Diseases of the genitourinary system. Urology
RC870-923
Mohamed Mohamed Elawdy
Yasser Osman
Diaa Eldin Taha
Mohamed H. Zahran
Samer El-Halwagy
Muftah El Garba
Ahmed M. Harraz
Risk factors and prognosis of intravesical recurrence after surgical management of upper tract urothelial carcinoma: A 30-year single centre experience
description Objective: To review the incidence, predictors and prognosis of bladder cancer recurrence after management of upper tract urothelial carcinoma (UTUC). Patients and methods: We retrospectively reviewed patients who were surgically treated for UTUC from 1983 to 2013. The tumours were categorised according to the 1997 Tumour-Node-Metastasis (TNM) staging and the three-tiered World Health Organization grading systems. The primary endpoint was the occurrence of any intravesical recurrence after treatment. We studied the possible risk factors that may contribute to development of intravesical recurrence, as well as the prognosis of the patients who had recurrence. Results: In all, 297 patients were eligible for analysis. Recurrent bladder tumours occurred in 139 patients (46.8%). The mean (range) time to recurrence after surgery was 33 (6–300) months. Neither sex, past history of bladder tumours, concomitant bladder tumour, the side of the tumour, UTUC stage, grade, presence of carcinoma in situ or multicentricity at the time of diagnosis of UTUC, were significant predictors of intravesical tumour recurrence. Ureteric tumour was the only identified risk factor (P = 0.02). Post-treatment bladder recurrence was a significant predictor of later urethral recurrence (P = 0.002). Conclusions: In our present series, bladder cancer recurrence of urothelial malignancy occurred in nearly half of the patients after surgical management of UTUC. Ureteric tumour was the only identifiable risk factor, thus patients with ureteric tumours may benefit from prophylactic intravesical chemoimmunotherapy. Bladder recurrence does not appear to affect the cancer-specific survival after surgical management of UTUC.
format article
author Mohamed Mohamed Elawdy
Yasser Osman
Diaa Eldin Taha
Mohamed H. Zahran
Samer El-Halwagy
Muftah El Garba
Ahmed M. Harraz
author_facet Mohamed Mohamed Elawdy
Yasser Osman
Diaa Eldin Taha
Mohamed H. Zahran
Samer El-Halwagy
Muftah El Garba
Ahmed M. Harraz
author_sort Mohamed Mohamed Elawdy
title Risk factors and prognosis of intravesical recurrence after surgical management of upper tract urothelial carcinoma: A 30-year single centre experience
title_short Risk factors and prognosis of intravesical recurrence after surgical management of upper tract urothelial carcinoma: A 30-year single centre experience
title_full Risk factors and prognosis of intravesical recurrence after surgical management of upper tract urothelial carcinoma: A 30-year single centre experience
title_fullStr Risk factors and prognosis of intravesical recurrence after surgical management of upper tract urothelial carcinoma: A 30-year single centre experience
title_full_unstemmed Risk factors and prognosis of intravesical recurrence after surgical management of upper tract urothelial carcinoma: A 30-year single centre experience
title_sort risk factors and prognosis of intravesical recurrence after surgical management of upper tract urothelial carcinoma: a 30-year single centre experience
publisher Taylor & Francis Group
publishDate 2017
url https://doaj.org/article/28437e20a2474d54a29d2ed08b104409
work_keys_str_mv AT mohamedmohamedelawdy riskfactorsandprognosisofintravesicalrecurrenceaftersurgicalmanagementofuppertracturothelialcarcinomaa30yearsinglecentreexperience
AT yasserosman riskfactorsandprognosisofintravesicalrecurrenceaftersurgicalmanagementofuppertracturothelialcarcinomaa30yearsinglecentreexperience
AT diaaeldintaha riskfactorsandprognosisofintravesicalrecurrenceaftersurgicalmanagementofuppertracturothelialcarcinomaa30yearsinglecentreexperience
AT mohamedhzahran riskfactorsandprognosisofintravesicalrecurrenceaftersurgicalmanagementofuppertracturothelialcarcinomaa30yearsinglecentreexperience
AT samerelhalwagy riskfactorsandprognosisofintravesicalrecurrenceaftersurgicalmanagementofuppertracturothelialcarcinomaa30yearsinglecentreexperience
AT muftahelgarba riskfactorsandprognosisofintravesicalrecurrenceaftersurgicalmanagementofuppertracturothelialcarcinomaa30yearsinglecentreexperience
AT ahmedmharraz riskfactorsandprognosisofintravesicalrecurrenceaftersurgicalmanagementofuppertracturothelialcarcinomaa30yearsinglecentreexperience
_version_ 1718398534710984704